Paula Esquivias et al.
World journal of gastroenterology, 18(35), 4866-4874 (2012-09-25)
To evaluate the effects of indomethacin [dual cyclooxygenase (COX)-1/COX-2 inhibitor] and 3-(3,4-difluorophenyl)-4-(4-(methylsulfonyl) phenyl)-2-(5H)-furanone (MF-tricyclic) (COX-2 selective inhibitor) in a rat experimental model of Barrett's esophagus and esophageal adenocarcinoma. A total of 112 surviving post-surgery rats were randomly divided into three